Why TPP Threatens To Undermine One Of The Fundamental Principles Of Science
August 11, 2015 | The TransPacific Partnership is stalled on data exclusivity--the protection of clinical trial data submitted to regulatory agencies from use by competitors. US pharma companies want the TPP to require a 12 year period of data exclusivity for clinical trial data for biologics. Techdirt